Antonius A.C.M. Heestermans

Author

Also Known As

A A C M Heestermans, A. A. C. M. Heestermans, A.A. Heestermans, A.A.C.M. HEESTERMANS, A.A.C.M. Heestermans, Antonius A Heestermans, Antonius A. C. M. Heestermans, Antonius A. Heestermans, Antonius A.C.M. Heestermans, Antonius Adrianus Cornelius Maria Heestermans

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Isala St. Antonius Ziekenhuis Medisch Centrum Alkmaar Radboud University Nijmegen Radboud University Medical Center

About

Antonius A.C.M. Heestermans is an author at Isala specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	220
2	Emergency Medicine	3	3	51
3	Public Health	2	2	38
4	Epidemiology	1	1	15
5	Pharmacology	1	1	169

Antonius A.C.M. Heestermans

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Predictors of Coronary Stent Thrombosis Jochem W. van Werkum, Antonius A.C.M. Heestermans, Anoek Zomer, Journal of the American College of Cardiology	2009	685
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium Julia Riegger, Robert A. Byrne, Michael Joner, European Heart Journal	2015	188
Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction Antonius A.C.M. Heestermans, Jochem W. van Werkum, Dirk Taubert, Thrombosis Research ThrombosisCardiovascular DiseaseAtherosclerosisPharmacologyCardiovascular Pharmacology	2008	169
Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis Jochem W. van Werkum, Antonius A.C.M. Heestermans, Fleur I. de Korte, Circulation	2009	164
Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older—rationale and design of the POPular AGE study Khalid Qaderdan, Maycel Ishak, Antonius A.C.M. Heestermans, American Heart Journal	2015	48
Association between angiographic culprit lesion and out-of-hospital cardiac arrest in ST-elevation myocardial infarction patients Matthijs A. Velders, Nick van Boven, H. Boden, Resuscitation Cardiovascular DiseaseMyocardial InfarctionPatient SafetyCardiovascular ImagingOut-of-hospital Cardiac Arrest	2013	23
Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial Jorik R. Timmer, Jurriën M. ten Berg, Antonius A.C.M. Heestermans, EuroIntervention	2010	15
Addition of routinely measured blood biomarkers significantly improves GRACE risk stratification in patients with myocardial infarction Majorie van Toorenburg, Victor J. van den Berg, Tjeerd van der Ploeg, International Journal of Cardiology ThrombosisBiomarker ResearchCardiovascular DiseaseAtherosclerosisGrace Risk Stratification	2018	15
A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI Antonius A.C.M. Heestermans, Renicus S. Hermanides, A.T. Marcel Gosselink, Netherlands Heart Journal Percutaneous Coronary InterventionThrombosisCardiovascular DiseasePrimary PciProvisional Use	2010	13
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial Renicus S. Hermanides, Antonius A.C.M. Heestermans, Jurriën M. ten Berg, Heart	2010	12

Page 1